2007'02.02.Fri
MEDIA ADVISORY: Roche in Oncology Media Fair
PR
May 31, 2006
Developing Oncology Solutions
Friday, 2 June 2006 (9:00 a.m. - 1:00 p.m.)
Atlanta Marriott Marquis Hotel
(For Non-U.S. Journalists Only)
WHAT: Exclusive preview of Roche worldwide oncology
franchise's
ground-breaking data.
Don't miss this unique opportunity to hear
first-hand about the
latest targeted and innovative therapies:
* Avastin: first anti-angiogenic agent for
breast, colorectal and
non-small cell lung cancer
* Bondronat: only single nitrogen
bisphosphonate for metastatic
bone disease
* Herceptin: first biologically engineered,
monoclonal antibody
to treat breast cancer
* Mabthera: the world's first monoclonal
antibody therapy for the
treatment of non-Hodgkin's lymphoma
* Tarceva: only EGFR-inhibitor with a survival
benefit in lung
cancer
* Xeloda: unsurpassed patient convenience with
an oral
chemotherapy regimen for breast and
colorectal cancers
WHY: -- Preview the latest cancer data from one of
the world's premiere
oncology portfolios
-- Access to leading oncology experts and Roche
senior executives
in a one-to-one interview format,
immediately following the
Media Fair
WHERE: Atlanta Marriott Marquis Hotel
Marquis Ballroom, Salon 3 (Media Fair Exhibit)
& Consulate Room
(Key Data Presentations)
265 Peachtree Avenue; Atlanta, Georgia USA
WHEN: Friday, 2 June 2006 (9:00 a.m. to 1:00 p.m.)
RSVP: To register for this event and to arrange
one-to-one interviews,
please contact Mitti Bose, Shire Health
International via phone at
+1-212-625-7140, mobile +1-917-804-9084 or via
e-mail at
mitti.bose@newyork.shirehealth.com. We suggest
you register prior
to June 2 to secure you're spot at the
briefing, however on-site
registration will be available with a press
badge/identification.
SOURCE Roche
Post your Comment
広告
ブログ内検索
アーカイブ
カウンター